Unit 3 - ATI Hematologic Drugs

Question 1

Altepase

Answer 1

Classification: thrombolytics

Therapeutic Use : treatment of acute myocardial infarction, deep-vein thrombosis, massive pulmonary emboli, ischemic cerebrovascular accidents, and re-establishing patency of occluded central IV catheters

Question 2

Clopidgrel

Answer 2

Classification: antiplatelet agents

Therapeutic Use: inhibition of platelet aggregation for risk reduction related to myocardial infarction, ischemic cerebrovascular accident, transient ischemic attacks, and coronary stents

Question 3

Cyanocobalamin

Answer 3

Classification: antianemics, vitamins

Therapeutic Use: treatment of pernicious anemia and vitamin B12 deficiency

Question 4

Desmopressin

Answer 4

Classification: antidiuretic hormones

Therapeutic Use” treatment of mild hemophilia A

Question 5

Enoxaparin

Answer 5

Classification: antithrombotics

Therapeutic Use: treatment of evolving cerebrovascular accident, pulmonary embolism, massive deep-vein thrombosis, and acute myocardial infarction, as well as prevention of postoperative venous thrombosis and pulmonary emboli

Question 6

Epoetin

Answer 6

Classification: erythropoiesis stimulating agents (ESA)

Therapeutic Use: supports production of erythrocytes in chronic renal failure, preoperative anemia, chemotherapy, and zidovudine (Retrovir) therapy for HIV

Question 7

Factor IX concentrate

Answer 7

Classification: antihemophilic factor

Therapeutic Use: treatment of hemophilia A (factor XIII) and hemophilia B (factor IX)

Question 8

Factor VIII concentrate

Answer 8

Classification: antihemophilic factor

Therapeutic Use: treatment of hemophilia A (factor XIII) and hemophilia B (factor IX)

Question 9

Ferrous sulfate

Answer 9

Classification : antianemics

Therapeutic Use: treatment of iron-deficiency anemia

Question 10

Filgrastim

Answer 10

Classification: colony-stimulating factors

Therapeutic Use: reduction of infection risk with bone marrow transplantation, severe chronic neutropenia, and myelosuppressive chemotherapy

Question 11

Folic Acid

Answer 11

Classification: antianemics, vitamins

Therapeutic Use: treatment of megaloblastic anemia a folate deficiency, and prevention of neural tube defects in developing fetus

Question 12

Heparin

Answer 12

Classification: treatment of evolving cerebrovascular

Therapeutic Use: treatment of evolving cerebrovascular accident, pulmonary embolism, massive deep-vein thrombosis, and acute myocardial infarction, as well as prevention of postoperative venous thrombosis and pulmonary emboli

Question 13

Iron dextran

Answer 13

Classification: antianemics

Therapeutic Use: treatment of iron-deficiency anemia

Question 14

Oprelvekin

Answer 14

Classification: thrombopoietic growth factor

Therapeutic Use: treatment of thrombocytopenia from myelosuppressive chemotherapy for nonmyeloid cancers

Question 15

Vitamin B12

Answer 15

Classification: Antianemics, vitamins

Therapeutic Use: treatment of pernicious anemia and vitamin B12 deficiency

Question 16

Warfarin

Answer 16

Classification: anticoagulants

Therapeutic Use: prevention of venous thrombosis and pulmonary embolism during atrial fibrillation and thromboembolism in clients who have prosthetic heart valves, as well as prevention of recurrent myocardial infarction and transient ischemic attacks